Florida’s litigation landscape has shifted considerably in the wake of HB 837 and the 2022–2023 insurance reform package. Reduced statutes of limitations, modified comparative fault rules, and curtailed attorney’s fee mechanisms have compressed margins on many traditional personal injury cases. Against that backdrop, mass tort litigation has emerged not merely as a complement to a plaintiff-side practice — but increasingly as its backbone.
Mass torts arise when a single defendant’s product, drug, or conduct injures a large number of individuals in substantially similar ways. Florida courts, both state and federal, have seen sustained activity in pharmaceutical litigation, medical device failures, environmental contamination claims, and product liability actions tied to defective consumer goods. For personal injury attorneys working under a tighter statutory environment, these dockets represent a category of claim that remains largely insulated from the fee-shifting changes that have squeezed single-plaintiff PI work.
Medical providers occupy a uniquely critical role in mass tort claims — one that is often underestimated until late in the litigation. In pharmaceutical and device cases, treating physicians, surgeons, and specialist providers are frequently called upon to establish the causal chain between a defective product and the specific injuries documented in their records. Clinical notes, operative reports, imaging findings, and post-treatment follow-up documentation become foundational exhibits. Providers who maintain thorough, contemporaneous records are invaluable; those whose documentation is sparse can inadvertently undermine even a wellconstructed claim.
There is also the matter of liens and letters of protection. In mass tort settlements — which often occur on a structured, multi-claimant basis — the negotiation of medical liens requires early coordination between attorneys and providers. Delayed provider engagement routinely results in disputes over settlement allocation that benefit neither party.
Florida’s large and aging population makes it a significant source of claimants in national mass tort dockets — from Camp Lejeune water contamination claims to ongoing CPAP device litigation and talcum powder cases. State-court mass torts involving Florida-specific exposures, such as agricultural chemical claims in rural counties or construction product failures in stormaffected regions, add another layer of local opportunity. Florida plaintiff attorneys with established referral networks and trusted medical provider relationships are well-positioned to build or join co-counsel arrangements that allow them to participate in these larger consolidated dockets without abandoning their existing practice infrastructure.
The calculus is straightforward: mass torts allow plaintiff-side practitioners to diversify their docket beyond the pressures of reformed PIP and property insurance litigation, while medical providers who understand the evidentiary demands of these cases can strengthen both their professional relationships and their revenue recovery outcomes. In a reshaped legal environment, that kind of strategic alignment isn’t just smart — it’s essential.
